Biome Australia Limited (ASX:BIO)

Market Cap	92.34M -13.7%
Revenue (ttm)	23.88M +29.7%
Net Income	3.61M +1,580.9%
EPS	0.02 +1,519.0%
Shares Out	228.00M
PE Ratio	25.47
Forward PE	25.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,175
Open	0.4050
Previous Close	0.4050
Day's Range	0.4000 - 0.4100
52-Week Range	0.2000 - 0.5100
Beta	0.96
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About Biome Australia

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company’s products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2018
• Employees: 30
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BIO

Financial Performance

In fiscal year 2026, Biome Australia's revenue was 23.88 million, an increase of 29.68% compared to the previous year's 18.42 million. Earnings were 3.61 million, an increase of 1580.93%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error